Jin Medical International (ZJYL) Current Deferred Revenue (2022 - 2025)
Historic Current Deferred Revenue for Jin Medical International (ZJYL) over the last 4 years, with Q1 2025 value amounting to -$303500.0.
- Jin Medical International's Current Deferred Revenue fell 7725.42% to -$303500.0 in Q1 2025 from the same period last year, while for Mar 2025 it was -$303500.0, marking a year-over-year decrease of 7725.42%. This contributed to the annual value of $671414.0 for FY2024, which is 544.78% down from last year.
- Per Jin Medical International's latest filing, its Current Deferred Revenue stood at -$303500.0 for Q1 2025, which was down 7725.42% from $671414.0 recorded in Q3 2024.
- Jin Medical International's 5-year Current Deferred Revenue high stood at $830305.0 for Q3 2022, and its period low was -$303500.0 during Q1 2025.
- Over the past 4 years, Jin Medical International's median Current Deferred Revenue value was $250095.5 (recorded in 2024), while the average stood at $240521.2.
- As far as peak fluctuations go, Jin Medical International's Current Deferred Revenue surged by 4175.45% in 2024, and later tumbled by 7725.42% in 2025.
- Jin Medical International's Current Deferred Revenue (Quarter) stood at $830305.0 in 2022, then fell by 14.48% to $710099.0 in 2023, then decreased by 5.45% to $671414.0 in 2024, then plummeted by 145.2% to -$303500.0 in 2025.
- Its Current Deferred Revenue was -$303500.0 in Q1 2025, compared to $671414.0 in Q3 2024 and -$171223.0 in Q1 2024.